Floatz logo

6 assets in Pediatric Systemic Lupus Erythematosus

Therapeutic assets addressing Pediatric Systemic Lupus Erythematosus, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Jnj-78436735
Pediatric Systemic Lupus Erythematosus
National Institute of Allergy and Infectious Diseases (NIAID)P2CCC (53)
Moderna Covid-19 Vaccine Rna
Pediatric Systemic Lupus Erythematosus
National Institute of Allergy and Infectious Diseases (NIAID)P2CCC (53)
Monovalent [B.1.351] Cov2 Pres Dtm-As03
Pediatric Systemic Lupus Erythematosus
National Institute of Allergy and Infectious Diseases (NIAID)P2CCC (53)
Methotrexate
Pediatric Systemic Lupus Erythematosus
National Institute of Allergy and Infectious Diseases (NIAID)P2CCC (52)
Tozinameran
Pediatric Systemic Lupus Erythematosus
National Institute of Allergy and Infectious Diseases (NIAID)P2CCC (50)
bnt162b2
Pediatric Systemic Lupus Erythematosus
National Institute of Allergy and Infectious Diseases (NIAID)P2CC (43)